Table:
Parameters	Subgroups by PSADT	P*
Slow	Fast
Local prostate cancer (n = 360)
Number of patients	219	141
Median PSADT (IQR), months	53.1 (29.1 - 119.7)	5.2 (2.8 - 9.3)	< 0.01
Median survival, months	151.2	77.8	Log-rank, p < 0.01
Local-advanced prostate cancer (n = 276)
Number of patients	177	99
Median PSADT (IQR), months	26.6 (13.2 – 58.5)	3.0 (1.4-4.9)	< 0.01
Median survival, months	Not estimated	69.3	Log-rank, p < 0.01
Metastatic prostate cancer (n = 276)
Number of patients	111	165
Median PSADT (IQR), months	9.8 (5.2-18.7)	1.3 (0.8 – 2.0)	< 0.01
Median survival, months	49.1	23.4	Log-rank, p < 0.01

Parse the diagram content behind with markdown code: | <ROWSPAN=2> Parameters | <COLSPAN=2> Subgroups by PSADT | <ROWSPAN=2> P* | 
 | Slow | Fast | 
 | --- | --- | --- | --- | 
 | Local prostate cancer (n = 360) |  |  |  | 
 | Number of patients | 219 | 141 |  | 
 | Median PSADT (IQR), months | 53.1 (29.1 - 119.7) | 5.2 (2.8 -

9.3) | < 0.01 | 
 | Median survival, months | 151.2 | 77.8 | Log-rank, p < 0.01 | 
 | Local-advanced prostate cancer (n = 276) |  |  |  | 
 | Number of patients | 177 | 99 |  | 
 | Median PSADT (IQR), months | 26.6 (13.2 – 58.5) | 3.0 (1.4-4.9) | < 0.01 | 
 | Median survival, months | Not estimated | 69.3 | Log-rank, p < 0.01 | 
 | Metastatic prostate cancer (n = 276) |  |  |  | 
 | Number of patients | 111 | 165 |  | 
 | Median PSADT (IQR), months | 9.8 (5.2-18.7) | 1.3 (0.8 – 2.0) | < 0.01 | 
 | Median survival, months | 49.1 | 23.4 | Log-rank, p < 0.01 |